Université de Bordeaux, ENSCBP, 16 avenue Pey Berland, 33607 Pessac Cedex, France.
J Control Release. 2010 Nov 1;147(3):428-35. doi: 10.1016/j.jconrel.2010.07.123. Epub 2010 Aug 6.
Doxorubicin (Dox), an anthracycline anticancer drug, was successfully incorporated into block copolymer vesicles of poly(trimethylene carbonate)-b-poly(L-glutamic acid) (PTMC-b-PGA) by a solvent-displacement (nanoprecipitation) method. pH conditions were shown to have a strong influence on loading capacity and release profiles. Substantial drug loading (47% w/w) was achieved at pH 10.5. After pH neutralization, aqueous dispersions of drug-loaded vesicles were found stable for a prolonged period of time (at least 6months) without vesicle disruption or drug precipitation. Dox-loaded vesicles exhibited in vitro pH and temperature-dependent drug release profiles: release kinetics fastened in acid conditions or by increasing temperature. These features strongly support the interest of developing PTMC-b-PGA polymersomes as carriers for the controlled delivery of Dox.
阿霉素(Dox)是一种蒽环类抗癌药物,通过溶剂置换(纳米沉淀)法成功地掺入到聚(三亚甲基碳酸酯)-b-聚(L-谷氨酸)(PTMC-b-PGA)嵌段共聚物囊泡中。结果表明,pH 值对载药量和释放曲线有很强的影响。在 pH 值为 10.5 时,实现了大量的药物负载(47%w/w)。在 pH 值中和后,载药囊泡的水相分散体在没有囊泡破裂或药物沉淀的情况下可以稳定地延长一段时间(至少 6 个月)。载药囊泡表现出 pH 值和温度依赖性的体外药物释放曲线:在酸性条件下或通过升高温度,释放动力学加快。这些特性强烈支持将 PTMC-b-PGA 聚合物囊泡开发为阿霉素控制释放载体的应用。